Suppr超能文献

用于胃滞留漂浮-脉冲给药的中空微球:制备与体外评价

Hollow microspheres for gastroretentive floating- pulsatile drug delivery: preparation and in vitro evaluation.

作者信息

Maghsoodi Maryam, Hemati Elham, Qadermazi Bahram, Yari Zahra

机构信息

Drug applied Research Center and Faculty of Pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran.

出版信息

Adv Pharm Bull. 2011;1(2):55-61. doi: 10.5681/apb.2011.008. Epub 2011 Dec 15.

Abstract

PURPOSE

A multiparticular floating-pulsatile drug delivery system was developed for time and site specific drug release of piroxicam. A blend of floating and pulsatile principles of drug delivery system would have the advantage that a drug can be released in the upper GI tract after a definite time period.

METHODS

Hollow microspheres were prepared by the emulsion solvent diffusion method using Eudragit S as an enteric acrylic polymer with piroxicam at various polymer/drug ratios in a mixture of dichloromethane and ethanol. Developed formulations were evaluated for yield, encapsulation efficiency, particle size, shape, apparent density, buoyancy studies and dissolution studies.

RESULTS

The obtained microballoons were spherical with no major surface irregularity and mean particle size ranging from 250 to 380 for different batches. Formulations show a slight amount of relaese ranging from 0.7 to 11% in acidic medium (SGF) with complete release of drug in simulated intestinal fluid (SIF) in less than 3 h. Encapsulation efficiency of different formulations varied from 90 to 98%. The optimum loading amount of drug in the particles was found to impart suitable floatable properties to the microballoons. With increasing polymer/drug ratio, buancy of the microballoons increases accompanied by simultaneous reduction of apparent particle density.

CONCLUSION

A pulsatile release of piroxicam was demonstrated by a simple drug delivery system which could be useful in chronopharmacotherapy of rheumatoid arthritis.

摘要

目的

开发一种多微粒漂浮-脉冲式药物递送系统,用于吡罗昔康的定时和定位药物释放。药物递送系统的漂浮和脉冲原理相结合具有这样的优势,即药物可在特定时间段后在上消化道释放。

方法

采用乳液溶剂扩散法,以Eudragit S作为肠溶丙烯酸聚合物,在二氯甲烷和乙醇的混合物中,按照不同的聚合物/药物比例,制备含吡罗昔康的中空微球。对所开发的制剂进行产率、包封率、粒径、形状、表观密度、漂浮性研究和溶出度研究。

结果

所获得的微球呈球形,表面无明显不规则,不同批次的平均粒径在250至380之间。制剂在酸性介质(模拟胃液)中的释放量为0.7%至11%,在模拟肠液中药物在不到3小时内完全释放。不同制剂的包封率在90%至98%之间。发现颗粒中药物的最佳负载量赋予微球合适的漂浮性能。随着聚合物/药物比例的增加,微球的漂浮性增加,同时表观颗粒密度降低。

结论

一种简单的药物递送系统证明了吡罗昔康的脉冲释放,这可能对类风湿性关节炎的时辰药物治疗有用。

相似文献

4
Low density multiparticulate system for pulsatile release of meloxicam.用于美洛昔康脉冲释放的低密度多颗粒系统。
Int J Pharm. 2006 Apr 26;313(1-2):150-8. doi: 10.1016/j.ijpharm.2006.02.001. Epub 2006 Mar 15.

本文引用的文献

2
pH-sensitive Eudragit nanoparticles for mucosal drug delivery.pH 敏感型 Eudragit 纳米粒用于黏膜给药剂型。
Int J Pharm. 2011 Jan 17;403(1-2):262-7. doi: 10.1016/j.ijpharm.2010.10.032. Epub 2010 Oct 31.
6
THE FLOW PROPERTIES OF MAGNESIA.氧化镁的流动特性。
J Pharm Pharmacol. 1964 Nov;16:705-16. doi: 10.1111/j.2042-7158.1964.tb07394.x.
7
Circadian rhythms in RA.类风湿关节炎中的昼夜节律
Ann Rheum Dis. 2003 Jul;62(7):593-6. doi: 10.1136/ard.62.7.593.
9
Characterization of piroxicam crystal modifications.吡罗昔康晶体变体的表征
Int J Pharm. 2003 Apr 30;256(1-2):3-15. doi: 10.1016/s0378-5173(03)00057-7.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验